We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Sigma® Life Science Creates World’s First Knock-in Rats using Zinc Finger Nuclease Technology

News   Dec 14, 2010

 
Sigma® Life Science Creates World’s First Knock-in Rats using Zinc Finger Nuclease Technology
 
 
Advertisement
 

RELATED ARTICLES

Genetic Engineering Explores How Cell Fate Is Determined in the Head

News

Mammalian embryonic development is an extremely complex and precise process. Researchers have shown how the gene Dlx5 helps direct the generation of tissues in the head.

READ MORE

A Long-Acting Injectable Therapy To Treat COVID-19

News

University of Liverpool researchers have demonstrated the potential of repurposing an existing drug called niclosamide into a long-acting injectable therapy that could be used to treat COVID-19.

READ MORE

Psychedelic “Experience” May Not Be Required for Antidepressant-Like Benefits

News

University of Maryland School of Medicine (UMSOM) researchers have shown that psilocybin—the active chemical in “magic mushrooms”— still works its antidepressant-like actions, at least in mice, even when the psychedelic experience is blocked.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE